CCL2 and esophageal squamous cell carcinoma: A dose‐dependent decrease of CCL2 in CAFs upon cultured with CM from imperatorin‐treated ESCC cells was confirmed at RNA, protein and secretion level by qRT‐PCR, Western blot and ELISA, respectively (Figure 4D–F).